Logo image of ACR.OL

AXACTOR ASA (ACR.OL) Stock Fundamental Analysis

Europe - Euronext Oslo - OSL:ACR - NO0010840515 - Common Stock

7.36 NOK
-0.02 (-0.27%)
Last: 12/15/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, ACR scores 3 out of 10 in our fundamental rating. ACR was compared to 10 industry peers in the Consumer Finance industry. ACR has a bad profitability rating. Also its financial health evaluation is rather negative. ACR has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ACR had negative earnings in the past year.
ACR had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ACR reported negative net income in multiple years.
In multiple years ACR reported negative operating cash flow during the last 5 years.
ACR.OL Yearly Net Income VS EBIT VS OCF VS FCFACR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

The Return On Assets of ACR (-4.57%) is worse than 80.00% of its industry peers.
ACR's Return On Equity of -16.24% is on the low side compared to the rest of the industry. ACR is outperformed by 80.00% of its industry peers.
The Return On Invested Capital of ACR (1.01%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.57%
ROE -16.24%
ROIC 1.01%
ROA(3y)-0.53%
ROA(5y)-1.09%
ROE(3y)-2.46%
ROE(5y)-4.4%
ROIC(3y)N/A
ROIC(5y)N/A
ACR.OL Yearly ROA, ROE, ROICACR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

With a Operating Margin value of 9.90%, ACR perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Looking at the Gross Margin, with a value of 98.12%, ACR is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
In the last couple of years the Gross Margin of ACR has grown nicely.
Industry RankSector Rank
OM 9.9%
PM (TTM) N/A
GM 98.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.03%
GM growth 5Y5.97%
ACR.OL Yearly Profit, Operating, Gross MarginsACR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACR is destroying value.
ACR has about the same amout of shares outstanding than it did 1 year ago.
ACR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ACR is higher compared to a year ago.
ACR.OL Yearly Shares OutstandingACR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ACR.OL Yearly Total Debt VS Total AssetsACR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

ACR has an Altman-Z score of 0.24. This is a bad value and indicates that ACR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.24, ACR is in line with its industry, outperforming 50.00% of the companies in the same industry.
ACR has a debt to FCF ratio of 4.17. This is a neutral value as ACR would need 4.17 years to pay back of all of its debts.
ACR's Debt to FCF ratio of 4.17 is fine compared to the rest of the industry. ACR outperforms 80.00% of its industry peers.
ACR has a Debt/Equity ratio of 2.25. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.25, ACR is doing worse than 60.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.25
Debt/FCF 4.17
Altman-Z 0.24
ROIC/WACC0.1
WACC9.65%
ACR.OL Yearly LT Debt VS Equity VS FCFACR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

ACR has a Current Ratio of 0.99. This is a bad value and indicates that ACR is not financially healthy enough and could expect problems in meeting its short term obligations.
ACR has a Current ratio (0.99) which is in line with its industry peers.
ACR has a Quick Ratio of 0.99. This is a bad value and indicates that ACR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.99, ACR perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.99
ACR.OL Yearly Current Assets VS Current LiabilitesACR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

The earnings per share for ACR have decreased strongly by -379.79% in the last year.
The Revenue for ACR has decreased by -37.28% in the past year. This is quite bad
The Revenue for ACR have been decreasing by -14.81% on average. This is quite bad
EPS 1Y (TTM)-379.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3100%
Revenue 1Y (TTM)-37.28%
Revenue growth 3Y-6.85%
Revenue growth 5Y-14.81%
Sales Q2Q%12.26%

3.2 Future

Based on estimates for the next years, ACR will show a very strong growth in Earnings Per Share. The EPS will grow by 35.41% on average per year.
ACR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.76% yearly.
EPS Next Y145.03%
EPS Next 2Y58.73%
EPS Next 3Y35.41%
EPS Next 5YN/A
Revenue Next Year51.52%
Revenue Next 2Y26.26%
Revenue Next 3Y17.76%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ACR.OL Yearly Revenue VS EstimatesACR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
ACR.OL Yearly EPS VS EstimatesACR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 -0.2

6

4. Valuation

4.1 Price/Earnings Ratio

ACR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 4.52, which indicates a rather cheap valuation of ACR.
ACR's Price/Forward Earnings ratio is rather cheap when compared to the industry. ACR is cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.78, ACR is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 4.52
ACR.OL Price Earnings VS Forward Price EarningsACR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

ACR's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, ACR is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.96
EV/EBITDA 37.95
ACR.OL Per share dataACR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

ACR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ACR's earnings are expected to grow with 35.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.73%
EPS Next 3Y35.41%

0

5. Dividend

5.1 Amount

ACR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

AXACTOR ASA

OSL:ACR (12/15/2025, 7:00:00 PM)

7.36

-0.02 (-0.27%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)10-29 2025-10-29/bmo
Earnings (Next)02-12 2026-02-12/amc
Inst Owners3.57%
Inst Owner ChangeN/A
Ins Owners6.03%
Ins Owner ChangeN/A
Market Cap2.22B
Revenue(TTM)147.84M
Net Income(TTM)-58.22M
Analysts75
Price Target9.59 (30.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.44%
Min EPS beat(2)-24.09%
Max EPS beat(2)15.21%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-6.81%
Min Revenue beat(2)-13.86%
Max Revenue beat(2)0.25%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.08%
PT rev (3m)-2.08%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)2.18%
EPS NY rev (3m)-9.28%
Revenue NQ rev (1m)-2.29%
Revenue NQ rev (3m)-2.29%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)5.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.52
P/S 1.26
P/FCF 0.96
P/OCF 0.94
P/B 0.52
P/tB 0.64
EV/EBITDA 37.95
EPS(TTM)-3.13
EYN/A
EPS(NY)1.63
Fwd EY22.1%
FCF(TTM)7.67
FCFY104.17%
OCF(TTM)7.8
OCFY105.93%
SpS5.83
BVpS14.13
TBVpS11.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.57%
ROE -16.24%
ROCE 1.25%
ROIC 1.01%
ROICexc 1.05%
ROICexgc 1.12%
OM 9.9%
PM (TTM) N/A
GM 98.12%
FCFM 131.59%
ROA(3y)-0.53%
ROA(5y)-1.09%
ROE(3y)-2.46%
ROE(5y)-4.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.03%
GM growth 5Y5.97%
F-Score3
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 2.25
Debt/FCF 4.17
Debt/EBITDA 32.14
Cap/Depr 31.37%
Cap/Sales 2.23%
Interest Coverage 0.2
Cash Conversion 787.27%
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.99
Altman-Z 0.24
F-Score3
WACC9.65%
ROIC/WACC0.1
Cap/Depr(3y)41.35%
Cap/Depr(5y)45.86%
Cap/Sales(3y)1.98%
Cap/Sales(5y)2.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-379.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3100%
EPS Next Y145.03%
EPS Next 2Y58.73%
EPS Next 3Y35.41%
EPS Next 5YN/A
Revenue 1Y (TTM)-37.28%
Revenue growth 3Y-6.85%
Revenue growth 5Y-14.81%
Sales Q2Q%12.26%
Revenue Next Year51.52%
Revenue Next 2Y26.26%
Revenue Next 3Y17.76%
Revenue Next 5YN/A
EBIT growth 1Y-86.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year118.31%
EBIT Next 3Y30.46%
EBIT Next 5YN/A
FCF growth 1Y1123.46%
FCF growth 3Y9.09%
FCF growth 5YN/A
OCF growth 1Y901.89%
OCF growth 3Y8.3%
OCF growth 5YN/A

AXACTOR ASA / ACR.OL FAQ

What is the ChartMill fundamental rating of AXACTOR ASA (ACR.OL) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACR.OL.


What is the valuation status for ACR stock?

ChartMill assigns a valuation rating of 6 / 10 to AXACTOR ASA (ACR.OL). This can be considered as Fairly Valued.


What is the profitability of ACR stock?

AXACTOR ASA (ACR.OL) has a profitability rating of 2 / 10.


Can you provide the dividend sustainability for ACR stock?

The dividend rating of AXACTOR ASA (ACR.OL) is 0 / 10 and the dividend payout ratio is 0%.